These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Synthesis, structures, and selective toxicity to cancer cells of gold(I) complexes involving N-heterocyclic carbene ligands. Boselli L; Ader I; Carraz M; Hemmert C; Cuvillier O; Gornitzka H Eur J Med Chem; 2014 Oct; 85():87-94. PubMed ID: 25078312 [TBL] [Abstract][Full Text] [Related]
32. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties. Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819 [TBL] [Abstract][Full Text] [Related]
33. Variable coordination of amine functionalised N-heterocyclic carbene ligands to Ru, Rh and Ir: C-H and N-H activation and catalytic transfer hydrogenation. Cross WB; Daly CG; Boutadla Y; Singh K Dalton Trans; 2011 Oct; 40(38):9722-30. PubMed ID: 21858341 [TBL] [Abstract][Full Text] [Related]
34. Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl Truong D; Sullivan MP; Tong KKH; Steel TR; Prause A; Lovett JH; Andersen JW; Jamieson SMF; Harris HH; Ott I; Weekley CM; Hummitzsch K; Söhnel T; Hanif M; Metzler-Nolte N; Goldstone DC; Hartinger CG Inorg Chem; 2020 Mar; 59(5):3281-3289. PubMed ID: 32073260 [TBL] [Abstract][Full Text] [Related]
35. Silver(I) complexes of mono- and bidentate N-heterocyclic carbene ligands: synthesis, crystal structures, and in vitro antibacterial and anticancer studies. Haque RA; Choo SY; Budagumpi S; Iqbal MA; Al-Ashraf Abdullah A Eur J Med Chem; 2015 Jan; 90():82-92. PubMed ID: 25461313 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands. Scattolin T; Caligiuri I; Mouawad N; El Boustani M; Demitri N; Rizzolio F; Visentin F Eur J Med Chem; 2019 Oct; 179():325-334. PubMed ID: 31255929 [TBL] [Abstract][Full Text] [Related]
38. Comparative solution equilibrium studies of antitumor ruthenium(η Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667 [TBL] [Abstract][Full Text] [Related]
39. DNA interaction, antioxidant activity, and bioactivity studies of two ruthenium(II) complexes. Han BJ; Jiang GB; Yao JH; Li W; Wang J; Huang HL; Liu YJ Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():840-9. PubMed ID: 25150435 [TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells. Zeng CC; Jiang GB; Lai SH; Zhang C; Yin H; Tang B; Wan D; Liu YJ J Photochem Photobiol B; 2016 Aug; 161():295-303. PubMed ID: 27288660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]